New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants

化学 丝氨酸蛋白酶 蛋白酵素 凝血酶 激肽释放酶 丝氨酸 药理学 小分子 凝结 生物化学 蛋白酶 酶 免疫学 生物 医学 血小板 内科学
作者
Ma’Lik D. Woodland,Anthony Thompson,Amanda Lipford,Navneet Goyal,John C. Schexnaildre,Madhusoodanan Mottamal,Daniel K. Afosah,Rami A. Al‐Horani
出处
期刊:ACS omega [American Chemical Society]
卷期号:9 (9): 10694-10708 被引量:2
标识
DOI:10.1021/acsomega.3c09335
摘要

Factor XIIa (FXIIa) functions as a plasma serine protease within the contact activation pathway. Various animal models have indicated a substantial role for FXIIa in thromboembolic diseases. Interestingly, individuals and animals with FXII deficiency seem to maintain normal hemostasis. Consequently, inhibiting FXIIa could potentially offer a viable therapeutic approach for achieving effective and safer anticoagulation without the bleeding risks associated with the existing anticoagulants. Despite the potential, only a limited number of small molecule inhibitors targeting human FXIIa have been documented. Thus, we combined a small library of 32 triazole and triazole-like molecules to be evaluated for FXIIa inhibition by using a chromogenic substrate hydrolysis assay under physiological conditions. Initial screening at 200 μM involved 18 small molecules, revealing that 4 molecules inhibited FXIIa more than 20%. In addition to being the most potent inhibitor identified in the first round, inhibitor 8 also exhibited a substantial margin of selectivity against related serine proteases, including factors XIa, Xa, and IXa. However, the molecule also inhibited thrombin with a similar potency. It also prolonged the clotting time of human plasma, as was determined in the activated partial thromboplastin time and prothrombin time assays. Subsequent structure–activity relationship studies led to the identification of several inhibitors with submicromolar activity, among which inhibitor 22 appears to demonstrate significant selectivity not only over factors IXa, Xa, and XIa, but also over thrombin. In summary, this study introduces novel triazole-based small molecules, specifically compounds 8 and 22, identified as potent and selective inhibitors of human FXIIa. The aim is to advance these inhibitors for further development as anticoagulants to provide a more effective and safer approach to preventing and/or treating thromboembolic diseases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
cc发布了新的文献求助10
1秒前
CipherSage的应助被xinxin采纳,获得10
2秒前
2秒前
2秒前
地动完成签到 ,获得积分10
2秒前
科研通AI6.2的应助被wangfei采纳,获得30
2秒前
long发布了新的文献求助10
3秒前
小羊发布了新的文献求助10
3秒前
3秒前
JamesPei的应助被楠楠采纳,获得10
3秒前
乐观碧彤发布了新的文献求助10
3秒前
4秒前
迷人雪卉完成签到,获得积分10
4秒前
李麟发布了新的文献求助10
5秒前
5秒前
5秒前
空集发布了新的文献求助10
5秒前
5秒前
6秒前
笔落惊风雨完成签到,获得积分10
6秒前
烨采发布了新的文献求助10
6秒前
6秒前
FashionBoy的应助被孤独口红采纳,获得30
7秒前
英俊的铭的应助被别晚睡采纳,获得10
7秒前
7秒前
7秒前
Lucas的应助被张长弓采纳,获得10
7秒前
7秒前
7秒前
抽烟酒牲发布了新的文献求助30
9秒前
9秒前
NexusExplorer的应助被lkh采纳,获得10
9秒前
ws123发布了新的文献求助10
10秒前
秀丽人杰完成签到,获得积分10
11秒前
dididi发布了新的文献求助10
11秒前
王添赟发布了新的文献求助10
11秒前
汉堡包的应助被Wdw2236采纳,获得10
11秒前
乐观碧彤完成签到,获得积分10
12秒前
molihuakai的应助被不是老羊采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188088
求助须知:如何正确求助?哪些是违规求助? 9575942
关于积分的说明 21844291
捐赠科研通 7785857
什么是DOI,文献DOI怎么找? 3435158
关于科研通互助平台的介绍 2559529
邀请新用户注册赠送积分活动 2482065